Pharmabiz13h
DFE Pharma expands its C2F Center of Excellence in Hyderabad to advance the development of critical respiratory treatments
DFE Pharma, a global leader in pharmaceutical and biopharmaceutical excipient solutions, has expanded the capabilities of its Closer to the Formulator (C2F) Center of Excellence located in Genome ...
Pharmabiz7h
Telix to buy next-generation therapeutic assets and innovative biologics technology platform from ImaginAb
Telix, a commercial-stage biopharmaceutical company, announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb, Inc. (ImaginAb) to acquire a pipeline of next ...
Pharmabiz9h
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced a pilot proteomics programme to analyze 50,000 UK Biobank samples in collaboration with deCODE Genetics, ...
Pharmabiz18h
China NMPA approves Sanofi’s Sarclisa in combo with pomalidomide and dexamethasone to treat adult patients with R/R multiple myeloma
China NMPA approves Sanofi’s Sarclisa in combo with pomalidomide and dexamethasone to treat adult patients with R/R multiple myeloma: Paris Tuesday, January 14, 2025, 10:00 Hrs ...
Pharmabiz5h
Telix enters agreement with Curium Pharma for transfer of marketing and distribution rights for Scintimun
Telix, a commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals, announces that it has entered ...
Pharmabiz4d
FPME demands policy reforms to address critical issues hampering export ecosystem
The Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME) has urged the authorities to address critical issues hampering India's pharmaceutical export ecosystem, highlighting the ...
Pharmabiz4d
Lupin’s ivacaftor oral granules receives US FDA tentative approval
Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for ...
Pharmabiz4d
WHO prequalifies SD Biosensor’s STANDARD G6PD System to support safer administration of P. vivax malaria treatments
The World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to ...
Pharmabiz4d
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor
Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, oral therapeutics for RAS-driven cancers, announced progress across its pipeline ...
Pharmabiz4d
NCH amends BHMS regulations to add goals, restructure curriculum and assessment process
The National Commission for Homoeopathy (NCH), the statutory body under the Ministry of Ayush to regulate the Homoeopathy education in the country, has amended the regulations related to Bachelor of ...
Pharmabiz4d
Novo Nordisk and Valo Health expand collaboration to discover and develop novel treatments for cardiometabolic diseases
Novo Nordisk A/S, a leading global healthcare company, and Valo Health, Inc. announced they have entered into an expanded agreement to discover and develop novel treatments for obesity, type 2 ...